Pharma putting digital drug delivery at heart of plans: survey Antibiotic-loaded microneedles show promise against MRSA Siga seeks FDA approval for intravenous smallpox therapy OliX allies with PCI to develop dermatological RNAi therapies Gene therapy biotech Gyroscope finds unnavigable seas on IPO market Call for your Fierce Biotech Fierce 15 nominations for 2021 Featured Story | By Nick Paul Taylor Almost 90% of pharmaceutical companies see smart inhalers and other digital drug delivery devices as very or extremely important to their future plans, according to a Molex survey. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor Microneedle patches have shown promise in the delivery of antibiotics locally to the skin, raising the prospects of being able to treat infections without subjecting patients to systemic therapy. read more By Nick Paul Taylor Siga Technologies has filed for FDA approval of an intravenous formulation of its smallpox treatment Tpoxx. The new formulation is designed to enable the treatment of patients who cannot swallow the already-approved capsules. read more By Nick Paul Taylor OliX Pharmaceuticals and PCI Biotech have partnered to develop dermatological RNAi therapies. The collaborators will use PCI’s intracellular delivery platform to try to get nucleic acids inside target cells. read more By Annalee Armstrong Gyroscope Therapeutics has taken a spin around the IPO market, only to find there is no path forward to reach the NASDAQ at this time. read more By Ben Adams Now in our nineteenth year, Fierce Biotech is once again seeking your nominations for the best, most exciting and innovative private biotechs. Last year, we wanted to see more COVID companies on the list, but this year there is a return to normality, and we will be happy to accept nominations from across all target areas. read more Resources Sponsored By: Veeva One top 10 pharma outlines three key steps to launching a modular content strategy to generate localized content faster. Sponsored By: Blue Matter This 77-page e-book explores 7 keys to success that any biopharma company needs to keep in mind as it enters Europe. Sponsored by: Datacubed Health The average clinical trial spends $40,000 per patient. Yet despite these high costs, most trials struggle to retain patients. Sponsored By: AmerisourceBergen Developing a quality product and getting it approved for distribution is not enough to guarantee commercial success. Sponsored By: WCG Trifecta The new standards in study training help sponsors and CROs reduce costs by 60%, cut training time by 50%, and start enrollment 55 days faster – learn more today. Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process intesification Sponsored By: August Bioservices How has COVID-19 impacted CRO/CDMO customer (dis)satisfaction and outsourcing decisions for pharma and biotech companies in 2021 and beyond? Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process development and manufacturing of your novel molecule Sponsored By: Remarque Systems Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. Sponsored By: BC Platforms Those wishing to unlock RWD’s true value must have access to a variety of data sources/types and the technological capabilities to use the data to uncover meaningful insights. Sponsored By: Oracle Health Sciences New research indicates an accelerated adoption of decentralized clinical trials due to COVID-19. Sponsored By: Within3 We enable virtual work — offering over-time sessions where participants are more focused, insights are more diverse and business goals are met. Sponsored by: Catalent Discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes. Sponsored by: Catalent This eBook features insights from experts in the industry on patient-centric drug development challenges and strategies on advancing drug design and development effectively. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Catalent In this webinar, pharmaceutical scientists present real-life examples of challenges they’ve overcome in the transfer of oral small molecules from a dedicated early-phase development site to a dedicated late-phase manufacturing site. TMF Virtual Summit May 18-20, 2021 | Virtual Event Next Gen: What’s beyond the leading edge of biotech and pharma? June 22-23, 2021 | Virtual Event | 